| KURA ONCOLOGY DL-,0001 |
| USA |
| Gesundheit |
| US50127T1097 / A143UH |
| KUR (Frankfurt) / KURA (NASDAQ) |
| FRA:KUR, ETR:KUR, KUR:GR, NASDAQ:KURA |
| - |
| https://kuraoncology.com/ |
|
Kura Oncology Inc. is a clinical-stage biopharmaceutical company dedicated to developing precision medicines for the treatment of cancer. The company's primary focus is on creating innovative therapie..
>Volltext.. |
| 641 Mio. EUR |
| 90.23 Mio. EUR |
| 58.14 Mio. EUR |
| - |
| -240.09 Mio. EUR |
| -2.74 EUR |
| 17.63 Mio. EUR |
| 128.46 Mio. EUR |
| - |
| 5.7 |
| 10.39% |
| -41.17% |
| - |
| - |
| - |
| - |
| KURA ONCOLOGY |
| 06.03.26 |
|